Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Singapore Industry Reporter.
Press releases published on June 26, 2025

Genius Group Board approves shareholder dividend, Bitcoin purchase from proceeds of future legal wins.
SINGAPORE, June 26, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that its Board of Directors have approved a distribution plan …

PERFORMANCE-CYCLING APPAREL - JOURN DROPS ITS SS25 COLLECTION WITH STYLE, SPIRIT, AND SPEED
Journ, the pioneering performance-lifestyle label born from the cycling scene, unveils its Spring/Summer 2025 (SS25) collection SINGAPORE, SINGAPORE, June 26, 2025 /EINPresswire.com/ -- Journ, the pioneering performance-lifestyle label born from the …

XRP News: Vaultro Finance Presale on XRP Rockets Past 80% Allocation — Only 20% Remains in Final Stretch
SINGAPORE, June 26, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance today announced that its $VLT Token Presale has surged past the 80% mark, leaving only 20% of $VLT tokens available in the final 72 hours of the offering. In a matter of days the sale has climbed …

Skywork.ai、Slides Agentの機能アップグレード:AIによるPPT⽣成の出⼒品 質を最適化、 ⽇本語能⼒が⼤幅に向上
SINGAPORE, June 26, 2025 (GLOBE NEWSWIRE) -- グローバルAIオフィスプラッ トフォーム「Skywork.ai」 は、 ⾃動プレゼンテーション⽣ 成機能「Slides Agent」の⼤規模アップグレー ドを発表しました。今回のアップデートでは、AIが⽣ 成するプレゼンテーシ ョ ンの出⼒品質向上に重点を置き、 ⽇本語ユーザーの習慣に合わせた複数の 最適化が⾏われました。 AI⽣成PPTはなぜ「作成は簡单だが、実⽤には課題が残る」のか AIによるPPT …

Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics
Percheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-VISTA mAb for further clinical development Hummingbird Bioscience stands to receive up to USD 290 million in upfront and milestone payments, plus royalties, from …